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SUMMARY
Objective: Placenta accreta can be managed with preservation of the uterus, especially when further fertility
is intended. We report a case of placenta accreta diagnosed intraoperatively and treated conservatively that
was followed by an ectopic pregnancy.
Case Report: A 32-year-old woman was found to have placenta accreta during cesarean section. Some pieces
of the placenta were left in situ after bleeding was controlled. The patient was followed up using levels of
`-human chorionic gonadotropin. Hysteroscopy revealed fibrotic and scar tissue at the site of retained placenta
1 year later. The patient did not conceive until 2 years later, but it was an ectopic pregnancy.
Conclusion: There are few reports of successful pregnancy following conservative treatment for placenta accreta.
Conservative treatment may increase the risk of secondary infertility, recurrent placenta accreta, and probably
ectopic pregnancy. [Taiwanese J Obstet Gynecol 2004;43(3):175–178]
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Introduction
Placenta accreta is defined as abnormally firm adher-
ence of placenta to the uterine wall [1]. The placenta
may extend into the myometrium (placenta increta) or
through the myometrium to the uterine serosa or
adjacent organs (placenta percreta). An abnormally
adherent placenta is associated with considerable
maternal morbidity such as severe hemorrhage, uter-
ine perforation and infection, and even mortality. The
incidence of placenta accreta is 1 in 7,000 to 1 in 1,900
pregnancies [1]. The standard treatment for placenta
accreta is hysterectomy. To preserve fertility, conserva-
tive treatment has been used in selected cases. We re-
port the first case of ectopic pregnancy after conserva-
tively treated placenta accreta and discuss the fertility
outcome of this condition.
Case Report
A 32-year-old woman, gravida 2, para 0, was referred
to our hospital at 31 weeks’ gestation for antepartum
hemorrhage. There was a history of abortion by dilatation
and curettage (D&C) in her first pregnancy. She had
had an uneventful prenatal course until this episode of
vaginal bleeding, which persisted for about 1 week. On
examination, vital signs were stable. There were regu-
lar uterine contractions and a reactive fetal heart rate.
Ultrasonography revealed a fetus with vertex presen-
tation and adequate size for gestational age. The pla-
centa was low-lying. Routine laboratory studies were
normal at admission. Rupture of the membrane was
noted on the fourth day of admission. Fever, leukocy-
tosis and elevated C-reactive protein were noted lat-
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er. Under the impression of chorioamnionitis, cesar-
ean section was arranged 10 days after admission.
A low transverse cesarean section was performed un-
der spinal anesthesia. A premature male infant weigh-
ing 1,944 g was delivered. He had Apgar scores of 7
and 9 at 1 and 5 minutes, respectively. An attempt
was made to remove the placenta manually, but no
satisfactory plane between the placenta and myometri-
um could be found. The placenta was ablated piece by
piece. Throughout the procedure, the patient’s bleeding
was fair and vital signs were stable. A 3 = 3 = 2 cm lobule
of the placenta deeply invaded the myometrial layer,
so the procedure was discontinued for fear of uterine
rupture. Meanwhile, the bleeding was well controlled at
the implantation site and at the retained placenta by
local methylergonovine, oxytocin, and prostaglandin
E2 injection. Vital signs, urinary output, and signs of
possible infection were closely monitored postopera-
tively. Parenteral oxytocin and methylergonovine were
administered. A broad-spectrum antibiotic was given to
treat infection. The patient was discharged on the fifth
postpartum day with uncomplicated recovery. Follow-
up serum `-human chorionic gonadotropin levels
became normal within 6 weeks and normal menstrual
cycles returned 12 weeks after delivery. The size of
the echo-complex shadow on the left lateral wall of
the uterus decreased gradually from 7 = 6 cm 1 month
postoperatively (Figure 1) to 1.6 = 1.0 cm 5 months
postoperatively (Figure 2).
This patient did not conceive in the subsequent
year. Hysteroscopic examination and biopsy showed a
2 = 2 cm light yellowish flat mass attached to the left
endometrial wall (Figure 3). Pathologic examination of
the tissue showed hyalinized fibrotic fragments with
prominent calcification.
One year later, she became pregnant. Unfortunately,
her early pregnancy course was complicated by vaginal
bleeding and lower abdominal pain, and a right tubal
pregnancy with internal bleeding was diagnosed. She
underwent emergency laparoscopic right salpingectomy
and was discharged the following day.
Discussion
Placenta accreta is defined as abnormal placentation
such that the villi attach directly to the myometrium,
without an intervening decidua. A definitive diagnosis
can only be made from histologic findings, but assump-
tive diagnosis should be made if there is difficulty in
separating the placenta. The incidence of placenta ac-
creta in a recent large-scale study was 1 in 111 deliv-
eries [2], compared with 1 in 7,000 to 1 in 1,900 in pre-
Figure 1. Ultrasound shows an endometrial mass (arrows) 1
month postoperatively.
Figure 2. Ultrasound shows an endometrial mass 5 months
postoperatively.
Figure 3. Hysteroscopic examination shows a light yellowish
flat fibrotic mass in the endometrial cavity.
vious studies [1], and 1 in 1,227 reported in our hospi-
tal [3]. Aside from variations in study populations and
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differences in definition, it is believed that the rising
incidence may be attributed to the rising number of
pregnancies with risk factors, including previous ce-
sarean delivery, advanced maternal age, high gravid-
ity, multiparity, and previous curettage and placen-
ta previa [2]. The curettage history in this case may be
associated with the placenta accreta.
Antenatal diagnoses of placenta accreta can be
made by color Doppler ultrasonography [4], magnetic
resonance imaging [5], and elevated serum _-fetopro-
tein levels [6]. Color Doppler ultrasound gives the most
specific diagnostic criteria such as diffuse or focal
intraparenchymal placental lacunar flow, bladder–
uterine serosa interphase hypervascularity, prominent
subplacental venous complex, and loss of subplacental
Doppler vascular signals [4]. However, the ultrasono-
graphic findings at first admission in this case were
unremarkable except for a low-lying placenta.
Cesarean hysterectomy remains the gold standard
treatment for placenta accreta. Conservation is con-
sidered only when the patient’s bleeding is not exces-
sive, hemodynamics are stable, and further fertility is
desired. Once conservative treatment has been chosen,
refractory hemorrhage during and after delivery and
intrauterine infection should be considered. Various
surgical and medical methods for hemostasis such as
direct packing, oversewing the uterine defect, wedge
resection of the implantation site, bilateral hypogastric
arterial occlusion, methotrexate injection, and sub-
endometrial vasopressin infiltration have been used
for conservative treatment [7,8]. Advances in antena-
tal diagnosis, improvements in antibiotics, and the mul-
tiple intraoperative hemostasis options make preser-
vation of the uterus more and more feasible.
Although infertility or subfertility was encountered
in our patient and others who have been treated con-
servatively, several cases of successful pregnancies
have been reported [9–17]. Remarkably, placenta ac-
creta recurred in almost half of the cases, which im-
plies another risk that should be taken into account in
the initial decision for conservation.
The association between previous placenta accreta
and ectopic pregnancy has not been established.
Theoretically, any condition that prevents or retards
migration of the fertilized ovum to the uterus could
predispose a woman to ectopic gestation [18]. The
known risk factors for ectopic pregnancy include cur-
rent use of an intrauterine device, a history of infertili-
ty, a history of pelvic inflammatory disease, prior tubal
surgery, prior spontaneous abortion, prior induced
abortion, and smoking [18–20]. Whether the retained
placenta affects subsequent implantation is unknown.
Intrauterine procedures such as D&C or hysteroscopy
are used for intrapartum management or postpartum
follow-up [13]. Retained placenta or oversewing of  the
implantation site may increase the chance of chronic
endometritis.
In conclusion, ectopic pregnancy following conser-
vatively treated placenta accreta is rare. The correlation
between ectopic pregnancy and previous placenta
accreta deserves further evaluation.
References
1. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC,
Wenstrom KD. Williams Obstetrics, 21st edition. New York:
McGraw-Hill, 2001:640–643.
2. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta
accreta – summary of 10 years: a survey of 310 cases. Placenta
2002;23:210–214.
3. Lee LC, Lin HH, Wang CW, Cheng WF, Huang SC. Successful
conservative management of placenta percreta with rectal
involvement in a primigravida. Acta Obstet Gynecol Scand 1995;
74:839–841.
4. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta
previa accreta by transabdominal color Doppler ultrasound.
Ultrasound Obstet Gynecol 2000;15:28–35.
5. Thorp JM, Councell RB, Sandrige DA, Wiest HH. Antepartum
diagnosis of placenta previa percreta by magnetic resonance
imaging. Obstet Gynecol 1992;80:506–508.
6. Zelop C, Nadel A, Frigoletto FD Jr, Pauker S, MacMillan M,
Benacerraf BR. Placenta accreta/percreta/increta: a cause of
elevated maternal serum alpha-fetoprotein. Obstet Gynecol
1992;80:693–694.
7. Schnorr JA, Singer JS, Udoff JA, Taylor PT. Late uterine wedge
resection of placenta increta. Obstet Gynecol 1999;94:823–
825.
8. Lurie S, Appleman Z, Katz Z. Subendometrial vasopressin to
control intractable placental bleeding. Lancet 1997;349:698.
9. Muir JC. Conservative treatment of placenta accreta with
subsequent normal pregnancy. Am J Obstet Gynecol 1948;56:
807.
10. McKeogh R, D’Errico E. Placenta accreta: clinical manifesta-
tions and conservative management. N Engl J Med 1951;245:
159–165.
11. Hutton L, Yang SS, Bernstein J. Placenta accreta: a 26-year
clinicopathologic review (1956–1981). NY State J Med 1983;
83:857–866.
12. Cox SM, Carpenter RJ, Cotton DB. Placenta percreta: ultra-
sound diagnosis and conservative surgical management.
Obstet Gynecol 1988;71:454–456.
13. Legro RS, Price FV, Caritis SN. Nonsurgical management of
placenta percreta: a case report. Obstet Gynecol 1994;83:
847–849.
14. Komulainen MH, Vayrynen MA, Kauko ML, Saarikoski S. Two
cases of placenta accreta managed conservatively. Eur J Ob-
stet Gynecol Reprod Biol 1995;62:135–137.
15. Palacios Jaraquemada JM, Pan G. Uterine conservation in
patient with consecutive double placenta percreta. Acta Ob-
stet Gynecol Scand 2000;79:900–901.
Taiwanese J Obstet Gynecol • September 2004 • Vol 43 • No 3178
C.K. Yang, et al
16. Morken NH, Henriksen H. Placenta percreta: two cases and
review of the literature. Eur J Obstet Gynecol Reprod Biol 2001;
100:112–115.
17. Kayem G, Pannier E, Goffinet F, Grange GG, Cabrol D. Fer-
tility after conservative treatment of placenta accreta. Fer-
til Steril 2002;78:637–638.
18. Marchbanks PA, Annegers JF, Coulam CB, Strathy JH, Kurland
LT. Risk factors for ectopic pregnancy. JAMA 1988;259:
1823–1827.
19. Bouyer J, Coste J, Shojaei T, Pouly JL, Fernandes H, Laurent
G, Job-Spira N. Risk factors for ectopic pregnancy: a compre-
hensive analysis based on a large case-control, population-
based study in France. Am J Epidemiol 2003;157:185–194.
20. Tharaux-Deneux C, Bouyer J, Job-Spira N, Coste J, Spira A.
Risk of ectopic pregnancy and previous induced abortion.
Am J Public Health 1998;88:401–405.
